We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Detection of Familial Pancreatic Neoplasms by Endoscopic Ultrasonography, MDCT, and MR Cholangiopancreatography

By HospiMedica International staff writers
Posted on 13 Aug 2008
Lives can be saved if high-grade dysplasia and early familial ductal adenocarcinoma can be detected in high-risk individuals before these lesions progress to advanced disease. More...
In a recent study, researchers evaluated different imaging modalities for preoperative detection of familial pancreatic neoplasms.

The investigators looked to characterize pancreatic neoplastic lesions detected by imaging tests in high-risk individuals; to compare the diagnostic yield and incremental benefit of endoscopic ultrasonography (EUS) over multidetector computed tomography (MDCT)/magnetic resonance cholangiopancreatography (MRCP); and to determine the incremental benefit of fine-needle aspiration (FNA) over EUS alone.

Data prospectively collected by investigators led by Marcia I. Canto, M.D., FASGE, an associate professor of medicine and oncology at Johns Hopkins University (Baltimore, MD, USA), from 1998-2007 from two screening studies and the center's clinical screening program were analyzed. High-risk individuals with Peutz-Jeghers syndrome or first-degree relatives from familial ductal adenocarcinoma kindreds with at least two affected, had MDCT or MRI/MRCP or both, and EUS. Radiologic and EUS features of each preoperatively detected lesion were compared with the pathologic findings. The diagnostic yield of each imaging modality was calculated on a per-lesion basis.

Of 165 patients who had EUS and CT/MRCP, 19 asymptomatic high-risk individuals underwent partial resection (15), partial followed by completion pancreatectomy (3), or total pancreatectomy (1) for 44 pancreatic lesions (size range 2.6-21 mm) detected by EUS, MDCT, or MRCP.

The researchers concluded that most pancreatic neoplasms detected by screening tests are small and low grade, but 6% of intraductal papillary mucinous neoplasms < 3 cm may contain high-grade dysplasia. EUS detects almost twice as many neoplastic lesions as CT/MRCP, regardless of size, and FNA adds little to EUS.

The study's findings were presented in May 2008, at the Digestive Disease Week (DDW) 2008, held in San Diego, CA, USA.

Related Links:
Johns Hopkins University


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.